Interact to see
Advertisement
Advertisement
DOXGX vs TQCRX
DOXGX vs TQCRX Comparison
Open Charts DOXGX vs TQCRX
Touchstone Dividend Equity R6
Price$18.63
Change-$0.20 (-1.06%)
VolumeN/A
Net Assets2.29B
DOXGX vs TQCRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
FUNDAMENTALS
Fundamentals
DOXGX has more cash in the bank: 114B vs. TQCRX (2.29B). TQCRX pays higher dividends than DOXGX: TQCRX (1.92) vs DOXGX (1.49). DOXGX was incepted earlier than TQCRX: DOXGX (3 years) vs TQCRX (4 years). TQCRX (0.92) is less costly to investors than DOXGX (0.46). TQCRX is a more actively managed with annual turnover of: 37.00 vs. DOXGX (15.00). DOXGX has a lower initial minimum investment than TQCRX: DOXGX (2500) vs TQCRX (50000). DOXGX annual gain was more profitable for investors over the last year : 6.03 vs. TQCRX (5.30).
| DOXGX | TQCRX | DOXGX / TQCRX | |
| Total Expense Ratio | 0.41 | 0.65 | 63% |
| Annual Report Gross Expense Ratio | 0.46 | 0.92 | 50% |
| Fund Existence | 3 years | 4 years | - |
| Gain YTD | 3.684 | 4.177 | 88% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 50000 | 5% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 114B | 2.29B | 4,985% |
| Annual Yield % from dividends | 1.49 | 1.92 | 78% |
| Returns for 1 year | 6.03 | 5.30 | 114% |
| Returns for 3 years | 28.44 | 24.58 | 116% |
| Returns for 5 years | N/A | N/A | - |
| Returns for 10 years | N/A | N/A | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBTCX | 20.46 | -0.13 | -0.63% |
| Fidelity Advisor Biotechnology C | |||
| MDGCX | 25.79 | -0.32 | -1.23% |
| BlackRock Advantage Global Investor A | |||
| SIECX | 12.09 | -0.17 | -1.39% |
| Saratoga International Equity C | |||
| RSIPX | 14.62 | -0.23 | -1.55% |
| Columbia Disciplined Core Inst2 | |||
| TMCIX | 14.89 | -0.26 | -1.72% |
| RBC SMID Cap Growth I | |||